MYC and lymphoma: A phase III randomized study (SWOG S9704) found that there was a trend favouring outcomes after consolidative auto‐HSCT in double protein‐expressing lymphoma (DPL) and MYC protein overexpressing patients, whereas all DHL patients have died irrespective of HSCT.6